Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Lee

Showing results (121-130 of 278) with videos related to

Pageof 28
Sort By:
Schizophrenia Research|March 31, 2015
Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS)Jeanette Lim, Gurpreet Rekhi, Attilio Rapisarda, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 1, 2016
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive SymptomsJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Brain, Behavior, & Immunity - Health|June 27, 2022
Haptoglobin in ultra-high risk of psychosis - Findings from the longitudinal youth at risk study (LYRIKS)Jie Yin Yee, Si Qing Chow, Keane Lim, et al.
Schizophrenia Research|October 13, 2023
Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in SingaporeZixu Yang, Hiroyoshi Takeuchi, Jie Yin Yee, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive SymptomsJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Histopathology|June 23, 2017
MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphomaWei-Ge Wang, Ze-Bing Liu, Xiang-Nan Jiang, et al.
Therapeutic Drug Monitoring|August 13, 2025
Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant SchizophreniaJiaqian Sun, Jie Yin Yee, Yuen Mei See, et al.
Oncoimmunology|February 1, 2020
Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppressionXiang-Nan Jiang, Bao-Hua Yu, Wan-Hui Yan, et al.
Schizophrenia Research|October 15, 2013
Unraveling the relationship between obesity, schizophrenia and cognitionNur Amirah Abdul Rashid, Jeanette Lim, Max Lam, et al.
The EMBO Journal|March 17, 2021
N<sup>6</sup> -methyladenosine modification of lncRNA Pvt1 governs epidermal stemnessJimmy Lee, Yuchen Wu, Bryan T Harada, et al.
Pageof 28

Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
Schizophrenia Research|March 31, 2015
Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS)Jeanette Lim, Gurpreet Rekhi, Attilio Rapisarda, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 1, 2016
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive SymptomsJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Brain, Behavior, & Immunity - Health|June 27, 2022
Haptoglobin in ultra-high risk of psychosis - Findings from the longitudinal youth at risk study (LYRIKS)Jie Yin Yee, Si Qing Chow, Keane Lim, et al.
Schizophrenia Research|October 13, 2023
Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in SingaporeZixu Yang, Hiroyoshi Takeuchi, Jie Yin Yee, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive SymptomsJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Histopathology|June 23, 2017
MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphomaWei-Ge Wang, Ze-Bing Liu, Xiang-Nan Jiang, et al.
Therapeutic Drug Monitoring|August 13, 2025
Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant SchizophreniaJiaqian Sun, Jie Yin Yee, Yuen Mei See, et al.
Oncoimmunology|February 1, 2020
Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppressionXiang-Nan Jiang, Bao-Hua Yu, Wan-Hui Yan, et al.
Schizophrenia Research|October 15, 2013
Unraveling the relationship between obesity, schizophrenia and cognitionNur Amirah Abdul Rashid, Jeanette Lim, Max Lam, et al.
The EMBO Journal|March 17, 2021
N<sup>6</sup> -methyladenosine modification of lncRNA Pvt1 governs epidermal stemnessJimmy Lee, Yuchen Wu, Bryan T Harada, et al.
Pageof 28